Date: 
Oct, 30 2014

Milan, October 30, 2014 - Sorin announces the financial calendar for 2015.

11 February      Board of Directors for the approval of the Preliminary 2014 results;
16 March          Board of Directors for the approval of the Draft 2014 Financial Statements;
29 April             Board of Directors for the approval of the First Quarter 2015 results;
30 April             Shareholders' Meeting;
30 July             Board of Directors for the approval of the First Half 2015 results;
27 October        Board of Directors for the approval of the Third Quarter 2015 results.

Changes to the above calendar will be communicated in advance.

                                                   * * *

About Sorin Group
Sorin Group (www.sorin.com), is a global medical device company and a leader in the treatment of cardiovascular diseases. The Company develops, manufactures and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. With over 3,500 employees worldwide, the Company focuses on two major therapeutic areas: Cardiac Surgery (cardiopulmonary products for open heart surgery and heart valve repair or replacement products) and Cardiac Rhythm Management (pacemakers, defibrillators, cardiac resynchronization devices). Every year, over one million patients are treated with Sorin Group devices in more than 80 countries.

For more information, please refer to www.sorin.com or contact:

Gabriele Mazzoletti
Director, Corporate Communications
Sorin Group
Tel: +39 02 69969785
Mobile: +39 348 9792201
e-mail: gabriele.mazzoletti@sorin.com		 Francesca Rambaudi
Director, Investor Relations
Sorin Group
Tel: +39 02 69969716
e-mail: investor.relations@sorin.com
.pdf
distributed by